News
Genoskin presents new skin cancer model at Meet2Win
Genoskin launches new OncoSkin® skin cancer model at Meet2Win Genoskin has developed a new skin cancer model for the in vitro study of melanoma. Patients who suffer from this highly dangerous type of skin cancer currently have limited therapeutic options when the cancer reaches metastasis. The OncoSkin® skin cancer model now enables in vitro studies on live melanoma spheroids implanted
Oriflame study uses NativeSkin® human skin explant model
NativeSkin®, a novel skin explant model for skin delivery assessment The Genoskin team is proud to announce that Oriflame Cosmetics published an article in the March 2015 edition of Cosmetics & Toiletries under the title “A Novel Skin Explant Model For Skin Delivery Assessment”. The work presented in this article was conducted by Oriflame’s cosmetics experts in their facility in Stockholm. Genoskin has
Genoskin joins 3R In Vitro Testing Platform IVTIP
Genoskin joins 3R In Vitro Testing Platform Genoskin is proud to join the In Vitro Testing Industrial Platform. The IVTIP Platform was founded in 1993 and currently comprises 46 companies from different sectors (assay developers, technology providers, chemical, pharmaceutical and cosmetics companies). All members have significant in vitro testing activities. Most of the IVTIP member companies are from Europe, but IVTIP also has members in
GENOSKIN to enter a business incubator in Toulouse
GENOSKIN has been selected on November 2011 to enter, by the end of 2012, the Centre Pierre Potier, a business incubator dedicated to biotech companies.
GENOSKIN to enter the Midi-Pyrénnées Incubator
The Board of Directors of the Nubbo Incubator (formerly Midi-Pyrénées Incubator) has given its approval for the support of GENOSKIN project.
Ex vivo human skin platforms for better non-clinical decisions. Labs in France and the USA, serving 500+ customers worldwide.